03004oam 2200697I 450 991082520470332120240131142323.01-136-29967-X1-283-64267-00-203-11657-71-136-29968-810.4324/9780203116579 (CKB)2670000000259449(EBL)1039376(OCoLC)812786701(SSID)ssj0000758356(PQKBManifestationID)12319347(PQKBTitleCode)TC0000758356(PQKBWorkID)10780746(PQKB)10081906(MiAaPQ)EBC1039376(Au-PeEL)EBL1039376(CaPaEBR)ebr10611744(CaONFJC)MIL395517(FINmELB)ELB135492(EXLCZ)99267000000025944920180706d2012 uy 0engur|n|---|||||txtccrOrganizations and the bioeconomy the management and commodification of the life sciences /Alexander Styhre1st ed.New York :Routledge,2012.1 online resource (203 p.)Routledge studies in management, organizations, and society ;18Description based upon print version of record.1-138-10734-4 0-415-52926-3 Includes bibliographical references and index.The concept of the bioeconomy -- Biopolitics, neoliberalism, and the calculative worldview : the economics of life -- New drug development, biotechnology and the enactment of life -- The tissue economy -- Living in and managing the bioeconomy.The advancement of the life sciences and the technosciences has enhanced the longevity of citizens in the Western world, and half of the generation born in the first decade of the new millennium is now expected to live to the age of one hundred years. In a society with such longevity and affluence, consumption of health-related goods and services such as pharmaceuticals and scanning procedures may be seen as a sustainable source of income for the industries that promote it. Though the healthcare sector has traditionally been organized in the public sector in Europe and in the private sectorManagement, organizations and society (London, England) ;v. 18.BiotechnologyEconomic aspectsLife sciencesEconomic aspectsBiotechnology industriesMedical economicsBiotechnologyEconomic aspects.Life sciencesEconomic aspects.Biotechnology industries.Medical economics.338.4/76606Styhre Alexander.616190MiAaPQMiAaPQMiAaPQBOOK9910825204703321Organizations and the bioeconomy3921794UNINA